Plus Therapeutics Inc’s recent filing unveils that its Director Lenk Robert P acquired Company’s shares for reported $53779.0 on Aug 22 ’25. In the deal valued at $0.49 per share,110,000 shares were bought. As a result of this transaction, Lenk Robert P now holds 139,327 shares worth roughly $58517.34.
Then, Petersen Greg bought 36,666 shares, generating $20,276 in total proceeds.
D. Boral Capital upgraded its Plus Therapeutics Inc [PSTV] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including D. Boral Capital’s analysts, who began to cover the stock in mid March with a ‘”a Buy”‘ rating. Ladenburg Thalmann began covering PSTV with “Buy” recommendation on January 25, 2021. Maxim Group started covering the stock on October 16, 2020. It rated PSTV as “a Buy”.
Price Performance Review of PSTV
On Monday, Plus Therapeutics Inc [NASDAQ:PSTV] saw its stock jump 1.85% to $0.42. Over the last five days, the stock has gained 2.52%. Plus Therapeutics Inc shares have fallen nearly -73.87% since the year began. Nevertheless, the stocks have fallen -63.19% over the past one year. While a 52-week high of $2.31 was reached on 03/07/25, a 52-week low of $0.16 was recorded on 06/18/25.
Levels Of Support And Resistance For PSTV Stock
The 24-hour chart illustrates a support level at 0.4113, which if violated will result in even more drops to 0.3994. On the upside, there is a resistance level at 0.4376. A further resistance level may holdings at 0.4520.
How much short interest is there in Plus Therapeutics Inc?
A steep rise in short interest was recorded in Plus Therapeutics Inc stocks on 2025-08-29, growing by 2.8 million shares to a total of 4.66 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 1.86 million shares. There was a rise of 60.03%, which implies that there is a positive sentiment for the stock.
